Skip to main content

Search

Clear
Filter by Type
Filter by Topics
Filter by Symptoms & Conditions
Filter by Year

APTA Results (5,286 Results)

Includes articles, courses, and CPGs. Unlimited access for APTA members.

Feds Recoup Relief Money From Providers Who Didn't Follow Reporting Rules

Mar 15, 2022/News

Some providers who received phase 1 CARES Act funds are being told to return the money. Phase 2 recipients can still set things right.

Many Different Ways to be an Active Member

Sep 29, 2019/Perspective

I had a sense of belonging. My journey of involvement began there.

Home Health: Expanded Use of Telecommunications Could Be Here to Stay

Jun 29, 2020/Review

The CMS home health payment rule for 2021 adopts changes implemented during the pandemic.

Expanded Health Reimbursement Arrangement Rule May Widen Use of the Employer Offering

Jun 28, 2019/News

An HHS change may make it easier for more Americans to purchase health insurance that they don't receive from their jobs.

Congress Reintroduces Bill That Would Help PTs Avoid Interruptions in Care

Feb 26, 2025/News

If enacted, PTs across the country would be allowed to secure substitute care for patients during an absence.

Wells Clinical Prediction Rule for Deep Vein Thrombosis

Aug 23, 2017/Test & Measure

It is completed by health care professionals and can be applied to any patient with a suspected DVT.

Patient-Reported Outcomes Measurement Information System (PROMIS) Physical Function (PF), PROMIS PF

May 16, 2019/Test & Measure

PROMIS PF is used as an outcome in research on the effectiveness of interventions.

Final 2023 Medicare Physician Fee Schedule: What You Need to Know, Part 1

Nov 3, 2022/Article

Payment is the focus of this installment: Cuts, therapy thresholds, updated calculations that could be good for PTs, and more.

MIPS and APMs: Where We Are Now

Apr 1, 2018/Column

It's time to prepare.

Defining Moment: Finding a Place to Call Home

Mar 12, 2024/Podcast

One PT takes a risk by opening a private practice with a mission to serve all.